Previous 10 | Next 10 |
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with this event. For further details see: Lantheus Holdings (LNTH) Investor Presentation
Highlights Piflufolastat F 18’s Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer Identified Regional Lymph Node and/or Distant Metastases in 26.9% of Patients Prior to Definitive Therapy NORTH BILLERICA, Mass.,...
NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and f...
aPROMISE was developed to quantify and standardize assessment of PSMA PET/CT images and will support PYLARIFY ® (piflufolastat F 18) adoption in the U.S. Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) announced today that its subsidiary, EXINI Diagnostics AB, was...
Image source: The Motley Fool. Lantheus Holdings, inc (NASDAQ: LNTH) Q2 2021 Earnings Call Jul 28, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Lantheus Holdings, inc (LNTH) Q2 2021 Earnings Call Transcript
Start Time: 08:00 End Time: 08:56 Lantheus Holdings, Inc. (LNTH) Q2 2021 Earnings Conference Call July 28, 2021, 08:00 AM ET Company Participants Mary Anne Heino - President and CEO Robert Marshall - CFO and Treasurer Paul Blanchfield - Chief Commercial Officer Mark Kinarney - Senior Director...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q2 - Results - Earnings Call Presentation
Worldwide revenue of $101.1 million for the second quarter 2021, representing an increase of 53.1% from the prior year period GAAP net loss of $26.7 million for the second quarter 2021, compared to GAAP net loss of $7.0 million in the prior year period GAAP fully dil...
[[ADP]],[[ALKS]],[[AMG]],[[APH]],[[ARCC]],[[AVY]],[[BA]],[[BG]],[[BMY]],[[BXMT]],[[CCJ]],[[CGEN]],[[CHEF]],[[CME]],[[CSTM]],[[DRVN]],[[DT]],[[EEFT]],[[EPD]],[[EVR]],[[EXP]],[[EXTR]],[[GD]],[[GIB]],[[GNRC]],[[GRMN]],[[HES]],[[HUM]],[[IART]],[[INMD]],[[LFUS]],[[LIVN]],[[LNTH]],[[MCD]],[[MCO]],[...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 28, 2021, to discuss its financial and operating results for the second quarter of 2021. To access the live con...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...